journal article·2025-01Open access

RNA‐Binding Protein Hnrnpa1 Triggers Daughter Cardiomyocyte Formation by Promoting Cardiomyocyte Dedifferentiation and Cell Cycle Activity in a Post‐Transcriptional Manner

Chuling Li, Yijin Chen, Qiqi Chen, Haoxiang Huang, Michael Hesse, Yilin Zhou, Ming Jin, Yu Liu, Yifei Ruan, Xiang He, Guoquan Wei, Hao Zheng, Senlin Huang, Guojun Chen, Wangjun Liao, Yulin Liao, Yanmei Chen, Jianping Bin

Advanced Science· Volume 12· Issue 2

Abstract

Abstract Stimulating cardiomyocyte (CM) dedifferentiation and cell cycle activity (DACCA) is essential for triggering daughter CM formation. In addition to transcriptional processes, RNA‐binding proteins (RBPs) are emerging as crucial post‐transcriptional players in regulating CM DACCA. However, whether post‐transcriptional regulation of CM DACCA by RBPs could effectively trigger daughter CM formation remains unknown. By performing integrated bioinformatic analysis of snRNA‐seq data from neonatal and adult hearts, this study identified Hnrnpa1 as a potential RBP regulating CM DACCA. Hnrnpa1 expression decreased significantly during postnatal heart development. With the use of α‐MHC‐H2B‐mCh/CAG‐eGFP‐anillin transgenic mice, Hnrnpa1 overexpression promoted CM DACCA, thereby triggering daughter CM formation and enhancing cardiac repair after myocardial infarction (MI). In contrast, CRISPR/Cas9 technology is used to generate CM‐specific Hnrnpa1 knockout mice. Hnrnpa1 knockout inhibited cardiac regeneration and worsened cardiac function in the neonatal MI model. Nanopore RNA sequencing, RIP assay, IP‐MS, MeRIP‐qPCR, PAR‐CLIP and luciferase reporter experiments showed that Hnrnpa1 induced Mettl3 post‐transcriptional splicing to inhibit m6A‐dependent Pbx1 and E2F1 degradation, thereby increasing Runx1, Ccne1, Cdk2 and Ccnb2 expression to promote CM DACCA. In conclusion, Hnrnpa1 triggered daughter CM formation by promoting CM DACCA in a post‐transcriptional manner, indicating that Hnrnpa1 might serve as a promising target in cardiac repair post‐MI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA modifications and cancer · RNA Research and Splicing · RNA and protein synthesis mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology State Key Laboratory of Organ Failure Research Nanfang Hospital Southern Medical University Guangzhou 510515 China

Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation Guangzhou 510515 China

Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory) Guangzhou 510005 China

Institute of Physiology I, Life and Brain Center Medical Faculty University of Bonn 53115 Bonn Germany

Department of Oncology Nanfang Hospital Southern Medical University Guangzhou 510515 China

Funding

National Natural Science Foundation of China · Guangzhou Regenerative Medicine and Health Guangdong Laboratory

References (62)

Show source-provided references
1. 10.1172/JCI8978610.1172/JCI89786 ↗
2. Shapiro S. D. · Sci. Transl. Med. · 2014 · 6
3. 10.1038/s41418-020-0492-510.1038/s41418-020-0492-5 ↗
4. 10.1038/nature1205410.1038/nature12054 ↗
5. 10.1126/science.119901010.1126/science.1199010 ↗
6. 10.1126/science.aar203810.1126/science.aar2038 ↗
7. 10.1016/j.cell.2009.04.06010.1016/j.cell.2009.04.060 ↗
8. 10.1161/CIRCRESAHA.119.31540810.1161/CIRCRESAHA.119.315408 ↗
9. Fang J. · Protein Cell · 2023 · 14 · 560
10. 10.1038/ncb314910.1038/ncb3149 ↗
11. 10.1161/CIRCULATIONAHA.122.06196010.1161/CIRCULATIONAHA.122.061960 ↗
12. 10.1161/CIRCULATIONAHA.116.02430710.1161/CIRCULATIONAHA.116.024307 ↗
13. 10.1242/jcs.0115910.1242/jcs.01159 ↗
14. 10.1126/sciadv.abi664810.1126/sciadv.abi6648 ↗
15. 10.3390/ijms2206328810.3390/ijms22063288 ↗
16. Jiang F. Q. · Elife · 2022 · 11
17. 10.1038/s41598-019-40939-210.1038/s41598-019-40939-2 ↗
18. 10.1016/j.semcdb.2014.05.01410.1016/j.semcdb.2014.05.014 ↗
19. 10.7554/eLife.7584410.7554/eLife.75844 ↗
20. 10.3389/fcell.2021.73897810.3389/fcell.2021.738978 ↗
21. Shi D. L. · Int. J. Mol. Sci. · 2022 · 23
22. 10.1152/physrev.00007.201910.1152/physrev.00007.2019 ↗
23. 10.1016/j.biocel.2013.08.00810.1016/j.biocel.2013.08.008 ↗
24. 10.1161/CIRCULATIONAHA.122.05934610.1161/CIRCULATIONAHA.122.059346 ↗
25. 10.1016/j.copbio.2019.12.00510.1016/j.copbio.2019.12.005 ↗
26. 10.1038/s12276-021-00615-w10.1038/s12276-021-00615-w ↗
27. 10.1016/j.devcel.2020.02.01910.1016/j.devcel.2020.02.019 ↗
28. 10.1038/s41421-019-0095-910.1038/s41421-019-0095-9 ↗
29. 10.1038/s41467-018-06639-710.1038/s41467-018-06639-7 ↗
30. 10.3389/fcvm.2023.123720810.3389/fcvm.2023.1237208 ↗
31. 10.1161/CIRCRESAHA.109.20900710.1161/CIRCRESAHA.109.209007 ↗
32. 10.1126/science.abo671810.1126/science.abo6718 ↗
33. 10.1038/s44161-022-00183-w10.1038/s44161-022-00183-w ↗
34. 10.1016/j.phrs.2021.10584510.1016/j.phrs.2021.105845 ↗
35. 10.1016/j.ymthe.2023.01.01110.1016/j.ymthe.2023.01.011 ↗
36. 10.1038/s41420-021-00688-610.1038/s41420-021-00688-6 ↗
37. 10.1186/s12864-020-07291-610.1186/s12864-020-07291-6 ↗
38. 10.1093/nar/gkab39310.1093/nar/gkab393 ↗
39. 10.1093/nar/gkw10410.1093/nar/gkw104 ↗
40. Zhao B. · Int. J. Mol. Sci. · 2022 · 23
41. 10.1007/s00395-015-0489-210.1007/s00395-015-0489-2 ↗
42. 10.1038/ncomms208910.1038/ncomms2089 ↗
43. 10.1161/CIRCRESAHA.118.31279210.1161/CIRCRESAHA.118.312792 ↗
44. 10.1038/nature1458210.1038/nature14582 ↗
45. 10.1016/j.freeradbiomed.2007.12.00710.1016/j.freeradbiomed.2007.12.007 ↗
46. 10.1007/s11010-007-9445-210.1007/s11010-007-9445-2 ↗
47. 10.7150/thno.5703710.7150/thno.57037 ↗
48. 10.1038/s41389-020-00282-y10.1038/s41389-020-00282-y ↗
49. 10.4161/sgtp.1.2.1410910.4161/sgtp.1.2.14109 ↗
50. 10.1161/CIRCULATIONAHA.119.04306710.1161/CIRCULATIONAHA.119.043067 ↗
51. 10.7150/thno.5724310.7150/thno.57243 ↗
52. 10.1371/journal.pbio.300168310.1371/journal.pbio.3001683 ↗
53. 10.1158/1541-7786.MCR-17-051410.1158/1541-7786.MCR-17-0514 ↗
54. 10.1091/mbc.E17-12-070810.1091/mbc.E17-12-0708 ↗
55. 10.1161/CIRCULATIONAHA.107.75923310.1161/CIRCULATIONAHA.107.759233 ↗
56. 10.7150/thno.4735410.7150/thno.47354 ↗
57. 10.1038/s12276-023-00944-y10.1038/s12276-023-00944-y ↗
58. 10.1002/cac2.1228110.1002/cac2.12281 ↗
59. 10.1016/j.omto.2021.04.01110.1016/j.omto.2021.04.011 ↗
60. 10.1002/j.1460-2075.1994.tb06883.x10.1002/j.1460-2075.1994.tb06883.x ↗
61. 10.1016/j.omtn.2022.10.01510.1016/j.omtn.2022.10.015 ↗
62. 10.1016/j.ymthe.2022.06.01610.1016/j.ymthe.2022.06.016 ↗